Alexandra Drakaki, MD, PhD of University of California, Los Angeles discusses what physicians need to know about the progress that’s being made with checkpoint inhibitors for treatment of Bladder Cancer at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
What Physicians Need to Know about the Use of Checkpoint Inhibitors for Bladder Cancer Treatment
